Early Diagnosis of Oral Cancer by Detecting p16 Hydroxymethylation
A Multicentral Prospective Study on Prediction of Malignant Progression of Oral Epithelial Dysplasia With p16 Hydroxymethylation
1 other identifier
observational
265
1 country
1
Brief Summary
The purpose of this study is to verify the function of p16 hydroxymethylation diagnostic reagents in early diagnosis of oral cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
November 16, 2016
CompletedFirst Posted
Study publicly available on registry
November 17, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2018
CompletedSeptember 25, 2017
September 1, 2017
4 years
November 16, 2016
September 20, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Cancer rate in patients with oral epithelial dysplasia containing or NOT containing p16 hydroxymethylation
Among these cases, oral specimens from 24 patients were p16-hydroxymethylation, 54 patients were p16-methylation and 187 patients were p16-unmethylation. The cancer rate in the p16-hydroxymethylation patients during the followup period will be compared with that in the other two groups.
from 3 months to 60 months
Secondary Outcomes (1)
Disease free survival of patients with oral epithelial dysplasia containing or Not containing p16 hydroxymethylation
from 3 months and 36 months
Study Arms (1)
p16 hydroxymethylation status
patients with p16 hydroxymethylation
Interventions
Eligibility Criteria
336 patients with mild or moderate oral epithelial dysplasia were selected. 145 of them are collected from Peking University of Stomatology and 165 were from Capital Medical University School of Stomatology and other 26 were from Fourth Military Medical University School of Stomatology.All of the patients with OED had been diagnosed pathologically by at least two senior pathologists using the criteria from '2005 WHO Classification System' and The oral tissue pathology diagnostic criteria (oral histopathology Edition Sixth).All cases involved primary lesions without any LASER, radiation therapy or chemotherapy.
You may qualify if:
- Histopathological diagnosis of oral lesions meet the epithelial diagnostic criteria for mild to moderate grade OED;
- No local area stimulate by residual root and crown, sharp cusp, poor restoration and biting cheek or lips;
- Without the treatment history by laser , radiation or chemical;
- Be able to Sign the informed consent;
You may not qualify if:
- Histopathological diagnosis of oral lesions do not meet the epithelium of mild to moderate dysplasia diagnostic criteria; histological diagnosis of severe grade OED or malignant disease;
- Pregnancy or breast-feeding women;
- Serious heart, lung, liver , kidney and other systemic diseases local area stimulate by residual root and crown, sharp cusp, poor restoration and biting cheek or lips;
- OED treatment history by LASER, radiotherapy, or chemotherapy;
- Tumor and psychiatric patients;
- Patients are unable to cooperate;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Beijing Municipal Administration of Hospitalslead
- Peking Universitycollaborator
Study Sites (1)
Peking University Cancer Hosptial and Institute
Beijing, Beijing Municipality, 100142, China
Related Publications (3)
Liu H, Liu XW, Dong G, Zhou J, Liu Y, Gao Y, Liu XY, Gu L, Sun Z, Deng D. P16 Methylation as an Early Predictor for Cancer Development From Oral Epithelial Dysplasia: A Double-blind Multicentre Prospective Study. EBioMedicine. 2015 Mar 23;2(5):432-7. doi: 10.1016/j.ebiom.2015.03.015. eCollection 2015 May.
PMID: 26137587BACKGROUNDCao J, Zhou J, Gao Y, Gu L, Meng H, Liu H, Deng D. Methylation of p16 CpG island associated with malignant progression of oral epithelial dysplasia: a prospective cohort study. Clin Cancer Res. 2009 Aug 15;15(16):5178-83. doi: 10.1158/1078-0432.CCR-09-0580. Epub 2009 Aug 11.
PMID: 19671846BACKGROUNDLiu H, Liu Z, Liu XW, Xu S, Wang L, Liu Y, Zhou J, Gu L, Gao Y, Liu XY, Shi H, Sun Z, Deng D. A similar effect of P16 hydroxymethylation and true-methylation on the prediction of malignant transformation of oral epithelial dysplasia: observation from a prospective study. BMC Cancer. 2018 Sep 24;18(1):918. doi: 10.1186/s12885-018-4787-6.
PMID: 30249192DERIVED
Biospecimen
Oral mucosal biopsy tissues were formalin fixed , paraffin embedded , sliced;or frozen tissues;
Study Officials
- STUDY DIRECTOR
Dajun Deng, MD
Peking University Cancer Hosptial and Institute
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
November 16, 2016
First Posted
November 17, 2016
Study Start
January 1, 2014
Primary Completion
January 1, 2018
Study Completion
January 1, 2018
Last Updated
September 25, 2017
Record last verified: 2017-09
Data Sharing
- IPD Sharing
- Will share
The number of the participants of different groups and the followup information will be shared with other researchers after the end of the study.